Skip to content
Open access · CC-BY via OpenAlex

The house cricket (Acheta domesticus) as a scalable invertebrate model for gerotherapeutic testing

Gerald Yu Liao, Jenna J Klug, Swastik Singh, Sherwin Dai, Elizabeth Bae, Warren Ladiges

Innovation in Aging · 2025

Abstract

Abstract The house cricket (Acheta domesticus) is a promising preclinical geroscience model due to its short lifespan, low maintenance, age-associated functional decline, and responsiveness to geroprotective drugs. Continuous dosing with mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), acarbose, and phenylbutyrate extends lifespan; whether intermittent dosing offers similar benefits remains unknown. We tested 274 sex-matched crickets given 2-week intermittent dosing of each drug starting at mid-age (8-weeks), followed by behavioral testing at 10-weeks (geriatric stage). Assays included Y-maze olfactory discrimination, open-field exploration, and treadmill performance. Locomotor gaits were identified by velocity-based K-means clustering (silhouette > 0.5). A subset was monitored for post-treatment survival using Kaplan-Meier analysis. Olfactory preference was preserved by all drugs (d = -1.82 to -1.28, P’s < 0.01), with strongest effects in rapamycin-treated individuals. Rapamycin-treated males matched or exceeded juvenile locomotor activity; phenylbutyrate reduced male activity (d = 1.49, P = 0.049) and acarbose increased walking-to-running ratios (d = -0.75, P = 0.029). Rapamycin increased central exploration and freezing (d = -1.55, P < 0.0001), while acarbose and phenylbutyrate increased peripheral freezing (d = -0.76, P = 0.02). Rapamycin and phenylbutyrate extended maximum running time (d = -2.30 to -1.32, P < 0.0001), with sex-specific jumping gains in rapamycin-treated females and acarbose-treated males. Post-treatment lifespan was prolonged by rapamycin (HR = 0.42, P = 0.0004) and reduced by acarbose in females (HR = 2.92 to 3.03, P’s < 0.05). Intermittent rapamycin preserved survival, cognition, and locomotion, while acarbose and phenylbutyrate produced selective benefits, supporting A. domesticus as a scalable model for geroprotective drug discovery.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/geroni/igaf122.533
Canonical
link ↗
Fetched
2026-10-12 MST

Cite this

APA
Liao, G.Y., Klug, J.J., Singh, S., Dai, S., Bae, E., &amp; Ladiges, W. (2025). The house cricket (Acheta domesticus) as a scalable invertebrate model for gerotherapeutic testing. <em>Innovation in Aging</em>. https://doi.org/10.1093/geroni/igaf122.533
Vancouver
Liao GY, Klug JJ, Singh S, Dai S, Bae E, Ladiges W. The house cricket (Acheta domesticus) as a scalable invertebrate model for gerotherapeutic testing. Innovation in Aging. 2025. doi:10.1093/geroni/igaf122.533.
BibTeX
@article{gerald2025Thehou, title = {The house cricket (Acheta domesticus) as a scalable invertebrate model for gerotherapeutic testing}, author = {Gerald Yu Liao and Jenna J Klug and Swastik Singh and Sherwin Dai and Elizabeth Bae and Warren Ladiges}, journal = {Innovation in Aging}, year = {2025}, doi = {10.1093/geroni/igaf122.533}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings